Business Wire

AHS to Launch $750 Million Casa AHS on Dubai Water Canal

20.5.2025 12:00:00 CEST | Business Wire | Press Release

Share

AHS Properties, the UAE’s leading ultra-luxury real estate developer, has announced the launch of Casa AHS, a landmark waterfront development valued at $750 million (AED 2.75 billion). Set along the prestigious Dubai Water Canal, the project redefines elite urban living with a curated collection of exceptional residences.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520255397/en/

AHS to Launch $750 Million Casa AHS on Dubai Water Canal (photo: AETOSWire)

Casa AHS is designed as a rare blend of architectural brilliance and branded elegance. The development is crafted by acclaimed architect Shaun Killa, with interiors by the renowned HBA Residential—redefining grandeur with expansive layouts, double-height ceilings (up to 12 meters), and awe-inspiring views of the Dubai Water Canal and Safa Park.

Commenting on the launch, Abbas Sajwani, Founder and CEO of AHS Properties, said: “With Casa AHS, we are creating more than just homes, we are curating a lifestyle that is deeply refined, emotionally resonant, and globally admired. This launch is a continuation of our mission to elevate luxury living in Dubai and offer our clients rare, statement-making properties in prime waterfront locations.”

The development will offer 32 ultra-luxury residences, including Sky Villas, Sky Mansions, and Sky Palaces, with sizes ranging from 5,088 to 29,700 sq. ft. Each residence features private elevators opening directly into lavish living rooms, private infinity-edge pools that seamlessly blend with the canal’s serene waters, jacuzzis, and expansive terraces for both tranquil relaxation and sophisticated entertaining.

Residents will enjoy a host of five-star amenities, including a private lounge and resident workspace, a tranquil spa and wellness oasis, and 24/7 concierge services accessible via a resident-only app. Additional offerings include exclusive access to a curated ultra-high-net-worth (UHNW) network, chauffeured limousine services and round-the-clock housekeeping. Each residence also comes with fully enclosed private garages, electric vehicle charging stations, dedicated bicycle storage, and secured private storage rooms.

About AHS Properties:

Founded in 2017 by Abbas Sajwani, AHS Group today boasts an impressive asset value of $2.7 billion and employs over 3,000 individuals, with ambitious plans to become one of the most vibrant business groups in the region. With a robust pipeline, AHS Properties targets $5 billion in GDV by the end of this year, continuing to set benchmarks in the luxury real estate market.

The company has achieved remarkable milestones, including the sale of high-value properties and the introduction of Casa Canal with Fendi Casa interiors.

In 2020, AHS Investments was launched, building a $150 million diversified portfolio across private and public equity. In 2021, Abbas launched AHS Properties, entering the luxury real estate market with projects in Palm Jumeirah and Emirates Hills, quickly earning recognition for innovation and quality.

New projects are on the horizon, promising to elevate luxury living. Each development is thoughtfully curated to offer unique experiences and expand the AHS portfolio, continuing our journey to set new benchmarks in the real estate landscape.

Source: AETOSWire

View source version on businesswire.com: https://www.businesswire.com/news/home/20250520255397/en/

Contacts

Sura Hammadin – PR & Media Director
Sura.Hammadin@ahs-properties.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye